Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

New review links obesity with accelerated biological aging mechanisms

The global rise in obesity and population aging represents a major public health challenge, with growing evidence suggesting that excess body fat not only increases the risk of chronic disease but may also accelerate the biological aging process. A new review

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

The global rise in obesity and population aging represents a major public health challenge, with growing evidence suggesting that excess body fat not only increases the risk of chronic disease but may also accelerate the biological aging process. A new review examines the close relationship between obesity and aging, highlighting the overlapping molecular mechanisms that link the two conditions and exploring whether anti-obesity therapies could help slow aging and reduce age-related disease.

The review explains that aging is driven by multiple biological hallmarks, including chronic inflammation, telomere shortening, mitochondrial dysfunction, genomic instability, impaired protein homeostasis, stem cell exhaustion, and altered nutrient sensing. Obesity appears to promote many of these same changes, suggesting that it acts as an accelerator of biological aging rather than simply increasing disease risk independently.

One of the strongest links between obesity and aging is chronic low-grade inflammation. Excess adipose tissue becomes infiltrated by immune cells that produce inflammatory cytokines, creating persistent systemic inflammation that contributes to insulin resistance, metabolic dysfunction, cardiovascular disease, and tissue damage. According to the review, this inflammatory state closely resembles the phenomenon of "inflammaging" observed during normal aging.

The authors also describe several additional mechanisms through which obesity may accelerate aging, including telomere depletion, epigenetic alterations, mitochondrial dysfunction, stem cell exhaustion, genomic instability, protein homeostasis disruption, cellular senescence, and gut microbiome dysbiosis. A summary diagram in the review illustrates these ten interconnected processes, emphasizing how obesity affects many of the same biological pathways that naturally deteriorate with age.

The review highlights evidence that weight loss interventions may partially reverse some of these aging-related changes. Lifestyle approaches such as calorie restriction and exercise, together with pharmacological treatments and bariatric surgery, have been associated with improvements in metabolic function and reductions in biological markers linked to aging. In particular, modern anti-obesity medications-including liraglutide, semaglutide, tirzepatide, and orlistat-are discussed for their potential to improve healthy lifespan by reducing inflammation, improving mitochondrial function, enhancing telomerase activity, and limiting oxidative stress.

Zhang, R., et al. (2026) Obesity accelerates aging: Mechanisms and therapeutic implications. Genes & Diseases. DOI: 10.1016/j.gendis.2025.101980. https://www.sciencedirect.com/science/article/pii/S2352304225004696?via%3Dihub

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What’s your vision for BenevolentBio?

I want us to disrupt the drug discovery and development process and to look at each place on the drug discovery and development pipeline, so that we can be much better at getting the right target, much quicker at getting the right compound and much more confident that those compounds have the right characteristics which mean they will be safe and well tolerated. Then we can go to the right patient population with the right dose, so we would have a much leaner, more successful process and be able to demonstrate the value of our AI technology.

Source: www.news-medical.net ↗
02What comes next?

We are now testing the drug in patients with earlier-stage pancreatic cancer, prescribing it while their tumors are still operable and before their cancer spreads.

Source: www.news-medical.net ↗
03What supplements really work?

The bulk of vitamins and supplements containing fish oil, biotin, and vitamins A, C, and E can potentially promote nail and hair growth. You can find dietary supplements with higher concentrations of vitamins and minerals that aid skin, hair, and nail health. Fish oil supplements make nails and hair shiny. Fish oil also serves as an agent that can decrease signs of aging. If sun exposure damages the skin, the omega-3 fatty acids in fish oil can help. Biotin, also known as B7, increases hair density and strengthens it. It is found naturally in bananas, eggs, and milk. Vitamins are vital for skin health as well. Vitamin A reduces acne flairs and helps with changes due to aging like wrinkling. A vitamin A deficiency may increase the risk of acne because it becomes difficult for dead skin to slough off hair follicles, blocking pores. Vitamin B lowers the risk of precancerous growths and nonmelanoma skin cancer. Vitamin C is an antioxidant. It leads the fight against free radicals to help stimulate collagen and brighten skin. It also helps to prevent the formation of unneeded melanin that causes uneven skin pigmentation.

Source: www.medicinenet.com ↗
04From Spirulina to Seaweed: How are different types of algae integral to human diets?

Algae are photosynthetic aquatic creatures that grow through the consumption of nutrients, light, and carbon dioxide. They are a diverse group of creatures that include tiny single-celled algae and enormous kelp, as well as seaweed 1. Numerous prokaryotic and eukaryotic algae species are desirable food sources for humans due to their inherent qualities 2,3. Human intake of macroalgae such as seaweed and microalgae like phytoplankton dates back many years. Multicellular macroscopic aquatic plants, or macroalgae, are classified into three taxa: Phaeophyceae, or brown algae, Rhodophyta or red algae, and Chlorophyta or green algae. Microalgae, the unicellular counterpart of macroalgae, are categorized in a broader framework that includes prokaryotic cyanobacteria (blue-green algae), Euglenophyta, and Chlorophyta, which are genetically distinct from one another. The ancient populations of Chad and the Aztec culture were already familiar with the cyanobacteria spirulina, which is currently advertised as a superfood in the West 4. In Burma, Vietnam, and India, other cyanobacteria/microalgae, like Spirogyra and Oedogonium, were eaten as food or as a supplement 4. Seaweed is a staple of daily meals in many Asian and Pacific civilizations, including Korea, Japan, and Indonesia, as well as Hawaii and New Zealand 5.

Source: www.news-medical.net ↗
05You have worked across the full drug development pipeline. How has that experience shaped your view of where AI can have the greatest impact in drug safety discovery?

Having worked across different parts of the discovery process, I think broad exposure changes the way you think. I have developed quantum chemistry, artificial intelligence (AI) and machine learning (ML) methods in research settings, but I have also had the chance to apply them in real discovery environments for materials and pharmaceuticals. That experience has shown me how different parts of the discovery pipeline interact, what their motivations are, and how they communicate. AI and ML have been used in early discovery for many years, but the biggest recent shift is in areas dominated by human processes and communication. Computers can now interact directly with human language and analytical images, opening new applications such as AI research assistants and AI-assisted dossier drafting. That means AI can start to work more collaboratively with scientists, although expert oversight and guardrails remain essential. In nonclinical safety, I think the biggest impact will be AI working alongside safety scientists to unearth key data, connect safety science with earlier discovery and later clinical work, and help process, predict, and summarize important outcomes. That could help safety science integrate more tightly with design, make, and test cycles in discovery, while also interfacing earlier with clinical science. Save a Copy of This Exclusive Interview by Downloading the Free PDF

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →